These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2656815)

  • 21. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions.
    Flechner SM; Kerman RH; Van Buren C; Kahan BD
    Transplantation; 1984 Jan; 37(1):73-6. PubMed ID: 6229913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of HLA mismatching on graft survival in living-donor kidney transplants: Catholic Medical Center, 1984 to 1993.
    Yoon YS; Jin DC; Yang CW; Kim SY; Bang BK; Kim WI; Koh YB
    Clin Transpl; 1993; ():275-83. PubMed ID: 7918161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of allogeneic cells on the human T and B cell repertoire.
    van Rood JJ; Claas FH
    Science; 1990 Jun; 248(4961):1388-93. PubMed ID: 1972596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood.
    Hendriks GF; van Steenberge EP; Schreuder GM; Wenting GJ; Mochtar B; Bos E; Simoons ML; Balk AH; Laird-Meeter K; Essed CE
    BMJ; 1988 Oct; 297(6653):888-90. PubMed ID: 3140966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
    Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH
    Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transfusion effect.
    Iwaki Y; Cecka JM; Terasaki PI
    Clin Transpl; 1988; ():283-92. PubMed ID: 3154480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine.
    Yasumura T; Kahan BD
    Transplantation; 1983 Dec; 36(6):603-9. PubMed ID: 6229068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
    Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Organ transplantation and blood transfusion].
    Matignon M; Bonnefoy F; Lang P; Grimbert P
    Transfus Clin Biol; 2011 Apr; 18(2):70-8. PubMed ID: 21398160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney retransplantation in the cyclosporine era.
    Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of HLA-DR antigen matching on the survival of cadaveric renal allografts. A prospective one-center analysis.
    Madsen M; Graugaard B; Fjeldborg O; Petersen VP; Hansen HE; Kissmeyer-Nielsen F
    Transplantation; 1983 Oct; 36(4):379-83. PubMed ID: 6353704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract]   [Full Text] [Related]  

  • 35. International study of histocompatibility in renal transplantation.
    Opelz G; Terasaki PI
    Transplantation; 1982 Jan; 33(1):87-95. PubMed ID: 7039026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin-A experience in Eurotransplant--preliminary data.
    Persijn GG; D'Amaro J
    Scand J Urol Nephrol Suppl; 1985; 92():91-3. PubMed ID: 3914069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living-donor renal transplantation in SEOPF. The impact of histocompatibility, transfusions, and cyclosporine on outcome.
    Sanfilippo F; Thacker L; Vaughn WK
    Transplantation; 1990 Jan; 49(1):25-9. PubMed ID: 2301022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal transplantation from HLA-haploidentical living-related donors: the effects of donor-specific blood transfusions and different immunosuppressive regimens.
    Sakagami K; Saito S; Shiozaki S; Fujiwara T; Haisa M; Niguma T; Kusaka S; Uda M; Matsuno T; Takasu S
    Acta Med Okayama; 1992 Feb; 46(1):1-5. PubMed ID: 1561899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful DR-incompatible cadaver kidney transplantation. Combined effect of HLA A and B matching and blood transfusion.
    Schulak JA; Goeken NE; Nghiem DD; Corry RJ
    Transplantation; 1984 Dec; 38(6):649-53. PubMed ID: 6390828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.